Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Eisai Korea Inc.

Home Clinical Trial Sponsors and OrganizationsEisai Korea Inc.

Eisai Korea Inc.

10/F Building Revessent, Seoul, South Korea

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

35

5 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

14

40.0%

Phase 1

4

11.4%

Trial Status Distribution

Active, not recruiting

5

14.3%

Completed

27

77.1%

Recruiting

2

5.7%

Terminated

1

2.9%

Clinical Trials

Trials sponsored by this organization (35)

A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

Active, not recruiting

Jun 202594 participants

A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

Feb 20253,000 participants

A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

Oct 2024118 participants

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

Feb 20242,040 participants

A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

Oct 2022125 participants

A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea

Apr 2022201 participants

A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients

Jun 2021135 participants

A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)

Jun 2021702 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials35
Approvals
News

Back to Organizations